Search results for: 'deaf+tech+and+benchmarking'
- Did you mean
- deal term and benchmarking
-
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025September 2025$3,995.00
Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Licensing Deals in Pharmaceuticals 2019-2025July 2025$4,995.00
Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Licensing Deals in Biotechnology 2019-2025July 2025$4,995.00
Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2025September 2025$3,995.00
Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Collaboration Deals in Biotechnology 2020-2025September 2025$4,995.00
Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More